SCHEMBL7317577

SCHEMBL7317577

COC(=O)[C@H](Cc1ccc(OCCCN2CCN(c3cccc(Cl)c3)CC2)cc1)NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.59
MMP1 P03956 1/20 0.50
MMP9 P14780 1/20 0.50
MMP13 P45452 1/20 0.50
ITGB1 P05556 4/20 0.45
ITGB7 P26010 1/20 0.45
USP2 O75604 1/20 0.45
HCRTR1 O43613 4/20 0.43
HCRTR2 O43614 4/20 0.43
FKBP1A P62942 2/20 0.43
ITGA5 P08648 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR1A P08908 1/20 0.41
KCNQ1 P51787 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314322 0.94 ITGA4 (0.65) ITGA4MMP1MMP9MMP13ITGB1
SCHEMBL7318497 0.88 ITGA4 (0.59) ITGA4MMP1ITGB1HCRTR1HCRTR2
SCHEMBL7327511 0.88 ITGA4 (0.58) ITGA4MMP1MMP13ITGB1HCRTR1
SCHEMBL7508252 0.85 ITGA4 (0.56) ITGA4MMP1MMP13ITGB1FKBP1A
SCHEMBL7317569 0.84 ITGA4 (0.58) ITGA4MMP1MMP13ITGB1HCRTR1
SCHEMBL9068818 0.83 ITGA4 (0.56) ITGA4ITGB1ITGB7HCRTR1HCRTR2
SCHEMBL7322188 0.82 ITGA4 (0.66) ITGA4MMP1ITGB1ITGB7FKBP1A
SCHEMBL7511221 0.81 ITGA4 (0.63) ITGA4MMP1MMP13ITGB1ITGB7
SCHEMBL6712426 0.81 ITGA4 (0.59) ITGA4ITGB1ITGB7HCRTR1HCRTR2
SCHEMBL7318157 0.81 ITGA4 (0.65) ITGA4MMP1ITGB1ITGB7FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed